24/05/2024  21:59:55 Chg. -0.24 Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
27.87USD -0.85% 139,801
Chiffrre d'affaires: 3.89 Mio.
-Bid taille: - -Ask la taille: - 3.8 Mrd.USD 3.44% -

Description de l'entreprise

Perrigo Company plc, a top five global over-the-counter ("OTC") consumer goods and pharmaceutical company, offers patients and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides Quality Affordable Healthcare Products® across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other markets, including Israel, China and Latin America.
 

Conseil d'administration & Conseil de surveillance

PDG
Murray S. Kessler
Conseil d'administration
Raymond Silcock, Grainne Quinn, James E. Dillard III, Rob Willis, Ron Janish, Svend Andersen, Todd W. Kingma, Tom Farrington
Conseil de surveillance
Rolf Classon, Adriana Karaboutis, Bradley Alford, Donal O'Connor, Erica L. Mann, Geoffrey M. Parker, Jeff Kindler, Katherine Doyle, Murray S. Kessler, Orlando D. Ashford, Theodore R. Samuels
 

Données de l'entreprise

Nom: Perrigo Company plc
Adresse: Treasury Building, Lower Grand Canal St.,IRL-Dublin 2, Ireland
Téléphone: +1-353-1709-4000
Fax: -
Courriel: -
Internet: www.perrigo.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 67.70%
IPO date: -

Relations avec les investisseurs

Nom: Bradley Joseph
Téléphone IR: +1-269-686-3373
IR-Fax: -
E-mail IR: bradley.joseph@perrigo.com

Calendrier de l'entreprise

CW 22 | 31/05/2024 Record Date
CW 22 | 31/05/2024 Ex-Dividend
CW 22 | 31/05/2024 Record Date
CW 25 | 18/06/2024 Dividend Payment
 

Principaux actionnaires

Freefloat
 
67.70%
T. Rowe Price Associates, Inc.
 
13.20%
The Vanguard Group
 
11.50%
BlackRock Inc.
 
7.60%